ENTASIS THERAPEUTICS HOLDINGS INC.

Inactive Instrument

Analyst Reco. Entasis Therapeutics Holdings Inc.

Equities

ETTX

US2936141033

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Downgrades Entasis Therapeutics Holdings to Neutral From Overweight, Adjusts Price Target to $2 From $5	22-05-06	MT
Wedbush Lifts Price Target on Entasis Therapeutics Holdings to $2 From $1.80 on Innoviva's Revised Bid, Maintains Neutral Rating	22-04-28	MT
Alliance Global Downgrades Entasis Therapeutics Holdings to Neutral From Buy	22-03-16	MT
Wedbush Cuts Entasis Therapeutics Holdings to Neutral From Outperform, Price Target to $1.80 From $9, Citing Acquisition Proposal	22-03-08	MT
HC Wainwright Downgrades Entasis Therapeutics Holdings to Neutral from Buy, Adjusts Price Target to $1.80 from $6	22-03-04	MT
ENTASIS THERAPEUTICS : BMO Capital Adjusts Price Target on Entasis Therapeutics Holdings to $7 From $5, Maintains Outperform Rating	21-10-20	MT
ENTASIS THERAPEUTICS : Wedbush Hikes Entasis Therapeutics' PT to $9 from $6 on Topline Data for Phase 3 ATTACK Study; Keeps Outperform; Shares Jump 13% Pre-Market	21-10-19	MT
Entasis Therapeutics : Says Phase 3 Trial of Antibiotic for Drug-Resistant Infection Shows Better Mortality Rate Versus Colistin; Shares Jump in Pre-Market	21-10-19	MT
Entasis Therapeutics : Says Phase 3 Trial of Antibiotic for Drug-Resistant Infection Shows Better Mortality Rate Versus Colistin; Shares Jump After Hours	21-10-18	MT
Entasis Therapeutics : Phase 3 Trial of Antibiotic for Drug-Resistant Infection Shows Better Mortality Rate Versus Colistin	21-10-18	MT
ENTASIS THERAPEUTICS : Wedbush Adjusts Entasis Therapeutics Holdings' Price Target to $6 From $7, Maintains Outperform Rating	21-05-06	MT
ENTASIS THERAPEUTICS : Credit Suisse Adjusts Entasis Therapeutics Holdings' Price Target to $6.50 From $8, Maintains Outperform Rating	20-11-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer